
Older Americans are quitting GLP-1 weight-loss drugs for 4 key reasons
Fox News
GLP-1 weight-loss drugs are being consistently discontinued by America's seniors due to cost, side effects and muscle loss, despite the benefits.
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care." Angelica Stabile is a lifestyle reporter for Fox News Digital.
Dr. John Batsis, a geriatrician and obesity specialist at the University of North Carolina School of Medicine, told The New York Times in a recent report that people over 65 years old are "prime targets" for this medication, as obesity prevalence is about 40% in older adults.
More Related News













